In rats with AA-induced colitis, treatment with RJ alleviated the damage of the colon tissue and the number of colonic CD3+CD45+ T cells and mast cells, without affecting the number of CD68+ macrophages and CD5+T cells. The gene discussed is CD5; the disease is colitis.